Rozanolixizumab to Treat Immune Thrombocytopenia | CheckRare.com

Tadeusz Robak, MD of the Poznań University of Medical Sciences in Poland provides a summary of a phase II clinical trial assessing rozanolixizumab for treat people with primary immune thrombocytopenia.

Read the full article here

Related Articles